ADVERTISEMENT

M. Alexander Otto

M. Alexander Otto began his reporting career early in 1999 covering the pharmaceutical industry for a national pharmacists' magazine and freelancing for the Washington Post and other newspapers. He then joined BNA, now part of Bloomberg News, covering health law and the protection of people and animals in medical research. Alex next worked for the McClatchy Company. Based on his work, Alex won a year-long Knight Science Journalism Fellowship to MIT in 2008-2009. He joined the company shortly thereafter. Alex has a newspaper journalism degree from Syracuse (N.Y.) University and a master's degree in medical science -- a physician assistant degree -- from George Washington University. Alex is based in Seattle.

Article

Young patients suffer most from PBC

Author:
M. Alexander Otto
Publish date: October 18, 2016

There is a linear relationship between age and quality of life (QoL) in patients with primary biliary cholangitis, with younger presenting patients...

News

Rise in HPV vaccination spurs CIN drop

Rise in HPV vaccination spurs CIN drop

Author:
M. Alexander Otto
Publish date: September 29, 2016

As HPV vaccination rates increased in New Mexico, the annual incidence of CIN1 among 15- to 19-year-old females dropped from 3,468 cases per 100,000 i...

Article

FDA approves biosimilar adalimumab

FDA approves biosimilar adalimumab

Author:
M. Alexander Otto
Publish date: September 27, 2016

There are “no clinically meaningful differences” between Amgen’s biosimilar adalimumab (Amjevita) and AbbVie’s branded prod...

Article

September 2016: Click for Credit

Author:
M. Alexander Otto
Publish date: September 1, 2016

Topics include: BRCA1 mutations and endometrial cancer risk • Treatment for scalp psoriasis • Azithromycin-resistant gonorrhea • Statins and...

ADVERTISEMENT